Ticker Symbol: SAVA
Cassava Sciences Inc
$61.69 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001069530
Company Profile
Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer's disease.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 7801 N Capital of Texas Hwy Ste 260
Website: www.paintrials.com
CEO: Remi Barbier
Tags:
- Pharmaceuticals: Other
- Health Technology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $17.54
Change:
$0.74
(
4.41%)
Days Range: $16.55 - $17.82
Beta: 1.41
52wk. High: $45.43
52wk. Low: $12.32
Ytd. Change -38.72%
50 Day Moving Average: $17.85
200 Day Moving Average: $21.32
Shares Outstanding: 41969994
Valuation
Market Cap: 73.6B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A